VR

Veeranki Rao Hanumanta

Active Director Director DIN 09388581
DIN 09388581 First appointment Nov 2021 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Veeranki Rao Hanumanta

Data last updated:

Veeranki Rao Hanumanta is a Director at Aditum Life Sciences Private Limited (since 2021). The company operates in Life Sciences.

DIN 09388581
Primary Designation Director
Industry Life Sciences
First Appointment 05 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aditum Life Sciences Private Limited U24299TG2021PTC150717
Director05 Nov 20212021Active

Board colleagues of Veeranki Rao Hanumanta

NameDINCompanyDesignation
Seyed Ehtesham Hasnain02205199Aditum Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aditum Life Sciences Private Limited
Premium access

Shareholding and investment profile for Veeranki Rao Hanumanta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veeranki Rao Hanumanta

Veeranki Rao Hanumanta currently holds 1 directorship: Aditum Life Sciences Private Limited (Director, since 05 Nov 2021).

Veeranki Rao Hanumanta was first appointed on 05 Nov 2021 as Director at Aditum Life Sciences Private Limited.

The current boards of Veeranki Rao Hanumanta's companies include Seyed Ehtesham Hasnain (Aditum Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available